Echo Systemic Sclerosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-24

Study Completion Date

2019-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Systemic sclerosis is an autoimmune connective tissue disease with undefined etiology and characterized by progressive fibrosis of the skin and major organs. Dry eyes and / or buccal syndrome is commonly reported in patients with systemic sclerosis. Goujerot-Sjogren syndrome is a chronic autoimmune disorder that is characterized by dryness of the eyes (xerophthalmia) and / or mouth (xerostomia). It may be primary or secondary to another connective tissue disease (such as lupus, rheumatoid arthritis or other). Several criteria have been validated to classify the SS but require a labial salivary gland biopsy, invasive act which complications can sometimes be reported (hematoma, lip sensory defect).

Several scores based on the evaluation of the ultrasound homogeneity of the salivary glands were developed but no studies have evaluated ultrasound abnormalities of salivary glands in patients with systemic sclerosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Examining the Immunological Process of Autoimmune Patients

NCT02123147

Sjogren's Syndrome Autoimmune Diseases Dry Eyes +1 more

WITHDRAWN

Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.

NCT05171114

Scleroderma, Systemic

COMPLETED NA

Oral Manifestations of Systemic Sclerosis

NCT02371005

Scleroderma, Systemic

TERMINATED NA

Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy

NCT03509064

Primary Sjögren Syndrome Small Fiber Neuropathy Quality of Life +1 more

RECRUITING

Optical Coherence Tomography Imaging in Systemic Sclerosis

NCT04532151

Systemic Sclerosis Early Systemic Sclerosis Without Clinical Scleroderma and Onset < 2 Years

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Descriptive explorative study of three population showing sicca symptoms (Systemic sclerosis, Gougerot-Sjogren syndrome, Sicca-Asthenia-Polyalgia syndrome).

Patient will be enrolled in the rheumatology department of University hospital of Clermont-Ferrand (France).

Salivary glands ultrasonography will be performed on all patients enrolled by the same expert and blinded to the diagnosis of the patient. Echostructure of the two salivary glands will be graded 0 to 4 and the size calculated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Systemic Sclerosis Gougerot Sjogren Syndrome Sicca-Asthenia-Polyalgia Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

* Systemic sclerosis diagnosis established by a rheumatologist and met ACR 2012 criteria
* Or primary Gougerot-Sjogren patient who met American-European Consensus Group (AECG) classification criteria.
* Or patient presenting a sicca syndrome but not met Gougerot-Sjogren criteria

Exclusion Criteria

* History of radiotherapy on face and neck
* Infection such as VIH or Hepatitis C
* Sarcoidosis
* Amylosis
* Wearing contact lenses
* Hyper IgG4 syndrome

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No